Revascularization for claudication in lower extremity peripheral arterial disease
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Usama Talib, BSc, MD [2]
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease[1]
Recommendation for Revascularization for Claudication in the Patient with PAD
Class IIa |
"1. Revascularization is a reasonable treatment option for the patient with lifestyle limiting claudication with an inadequate response to GDMT.(Level of Evidence: A)" |
Recommendations for Endovascular Revascularization for Claudication:
Class I |
"1. Endovascular procedures are effective as a revascularization option for patients with lifestyle-limiting claudication and hemodynamically significant aortoiliac occlusive disease.(Level of Evidence: A)" |
Class III (Harm) |
"1. Endovascular procedures should not be performed in patients with PAD solely to prevent progression to CLI.(Level of Evidence: B-NR)" |
Class IIa |
"1.Endovascular procedures are reasonable as a revascularization option for patients with lifestyle-limiting claudication and hemodynamically significant femoropopliteal disease.(Level of Evidence: B-R)" |
Class IIb |
"1.The usefulness of endovascular procedures as a revascularization option for patients with claudication due to isolated infrapopliteal artery disease is unknown.(Level of Evidence: C-LD)" |
Recommendations for Surgical Revascularization for Claudication:
Class I |
"1. When surgical revascularization is performed, bypass to the popliteal artery with autogenous vein is recommended in preference to prosthetic graft material.(Level of Evidence: A)" |
Class III (Harm) |
"1. Femoral-tibial artery bypasses with prosthetic graft material should not be used for the treatment of claudication.(Level of Evidence: B-R)" |
"2. Surgical procedures should not be performed in patients with PAD solely to prevent progression to CLI.(Level of Evidence: B-NR)" |
Class IIa |
"1.Surgical procedures are reasonable as a revascularization option for patients with lifestyle-limiting claudication with inadequate response to GDMT, acceptable perioperative risk, and technical factors suggesting advantages over endovascular procedures.(Level of Evidence: B-NR)" |
References
- ↑ Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE; et al. (2016). "2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". Circulation. doi:10.1161/CIR.0000000000000471. PMID 27840333.